Osborne Partners Capital Management LLC decreased its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 0.4% during the second quarter, Holdings Channel reports. The institutional investor owned 41,943 shares of the pharmacy operator’s stock after selling 150 shares during the period. Osborne Partners Capital Management LLC’s holdings in Walgreens Boots Alliance were worth $3,285,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of the stock. Patten & Patten Inc. TN raised its stake in Walgreens Boots Alliance by 1.1% in the first quarter. Patten & Patten Inc. TN now owns 112,309 shares of the pharmacy operator’s stock worth $9,327,000 after buying an additional 1,172 shares in the last quarter. Bank of The West raised its stake in Walgreens Boots Alliance by 19.5% in the first quarter. Bank of The West now owns 10,073 shares of the pharmacy operator’s stock worth $837,000 after buying an additional 1,643 shares in the last quarter. DnB Asset Management AS raised its stake in Walgreens Boots Alliance by 15.8% in the first quarter. DnB Asset Management AS now owns 115,652 shares of the pharmacy operator’s stock worth $9,605,000 after buying an additional 15,800 shares in the last quarter. Gateway Investment Advisers LLC raised its stake in Walgreens Boots Alliance by 5.5% in the first quarter. Gateway Investment Advisers LLC now owns 643,219 shares of the pharmacy operator’s stock worth $53,419,000 after buying an additional 33,652 shares in the last quarter. Finally, Vicus Capital raised its stake in Walgreens Boots Alliance by 2.8% in the first quarter. Vicus Capital now owns 3,270 shares of the pharmacy operator’s stock worth $272,000 after buying an additional 88 shares in the last quarter. 61.16% of the stock is owned by institutional investors.

Walgreens Boots Alliance, Inc. (NASDAQ WBA) traded down 0.47% during trading on Friday, reaching $80.51. The company had a trading volume of 2,000,002 shares. Walgreens Boots Alliance, Inc. has a 52-week low of $75.18 and a 52-week high of $89.69. The company has a 50 day moving average price of $79.56 and a 200 day moving average price of $82.29. The company has a market capitalization of $86.15 billion, a PE ratio of 20.33 and a beta of 1.25.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.30 by $0.03. The firm had revenue of $30.12 billion for the quarter, compared to analysts’ expectations of $29.72 billion. Walgreens Boots Alliance had a return on equity of 17.34% and a net margin of 3.69%. The business’s quarterly revenue was up 2.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.18 EPS. On average, equities analysts forecast that Walgreens Boots Alliance, Inc. will post $5.00 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 12th. Shareholders of record on Friday, August 18th will be paid a $0.40 dividend. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. The ex-dividend date is Wednesday, August 16th. This represents a $1.60 annualized dividend and a yield of 1.98%. Walgreens Boots Alliance’s payout ratio is presently 40.30%.

Walgreens Boots Alliance declared that its board has authorized a stock buyback program on Thursday, June 29th that authorizes the company to buyback $5.00 billion in outstanding shares. This buyback authorization authorizes the pharmacy operator to reacquire up to 5.9% of its shares through open market purchases. Shares buyback programs are generally a sign that the company’s leadership believes its shares are undervalued.

TRADEMARK VIOLATION NOTICE: This article was published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this article on another site, it was illegally copied and republished in violation of US & international copyright & trademark legislation. The original version of this article can be viewed at https://www.thecerbatgem.com/2017/08/18/osborne-partners-capital-management-llc-has-3-29-million-position-in-walgreens-boots-alliance-inc-wba.html.

A number of analysts have commented on the stock. Zacks Investment Research lowered shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Wednesday, June 14th. BidaskClub upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a report on Thursday, August 3rd. Jefferies Group LLC dropped their target price on Walgreens Boots Alliance from $95.00 to $80.00 and set a “buy” rating on the stock in a report on Wednesday, May 31st. Needham & Company LLC set a $94.00 target price on Walgreens Boots Alliance and gave the company a “buy” rating in a report on Monday, July 17th. Finally, Citigroup Inc. reiterated a “buy” rating on shares of Walgreens Boots Alliance in a report on Monday, July 3rd. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating and fourteen have given a buy rating to the company. The company presently has a consensus rating of “Buy” and an average target price of $90.69.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction that occurred on Tuesday, July 25th. The stock was sold at an average price of $79.79, for a total value of $218,305.44. Following the sale, the director now owns 19,151 shares in the company, valued at approximately $1,528,058.29. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 13.50% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Stock Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related stocks with our FREE daily email newsletter.